TY  - GEN
AU  - van Helden,Erik J
AU  - Angus,Lindsay
AU  - Menke-van der Houven van Oordt,C Willemien
AU  - Heideman,Daniëlle A M
AU  - Boon,Eline
AU  - van Es,Suzanne C
AU  - Radema,Sandra A
AU  - van Herpen,Carla M L
AU  - de Groot,Derk Jan A
AU  - de Vries,Elisabeth G E
AU  - Jansen,Maurice P H M
AU  - Sleijfer,Stefan
AU  - Verheul,Henk M W
TI  - RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer
SN  - 1878-0261
PY  - 2020///0619
KW  - Aged
KW  - Aged, 80 and over
KW  - Cetuximab
KW  - therapeutic use
KW  - Circulating Tumor DNA
KW  - blood
KW  - Colorectal Neoplasms
KW  - DNA Mutational Analysis
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - genetics
KW  - Neoplasm Staging
KW  - Proto-Oncogene Proteins B-raf
KW  - Treatment Outcome
KW  - ras Proteins
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/1878-0261.12550
ER  -